FIELD: medicine.
SUBSTANCE: to implement the invention, a viscoelastic solution with a hyaluronic acid content of 2.5%, molecular weight of 3⋅106 D and a zero shear viscosity of 103 PaS is injected⋅ subconjunctivally. This solution is administered immediately after muscle fixation to the sclera before conjunctiva suturing under visual control. The solution is administered under the operated oculomotor muscle in a volume that provides its envelopment. Then, after conjunctiva suturing, the solution is injected into the subconjunctival space in a volume that provides conjunctiva separation from the sclera and muscle.
EFFECT: pronounced antiscar effect after operations in the region of oculomotor muscles.
3 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF REPEATED SURGICAL TREATMENT OF STRABISMUS BY METHOD OF REGULATED JOINTS | 2015 |
|
RU2598801C1 |
| METHOD FOR SURGICAL MANAGEMENT OF REPEATEDLY OPERATED STRABISMUS WITH HYPERACTIVE EFFECT | 2018 |
|
RU2698440C1 |
| METHOD FOR CARRYING OUT THE NEEDLING OF A SCAR-MODIFIED FILTRATION PAD | 2022 |
|
RU2782501C1 |
| METHOD FOR SURGICAL TREATMENT OF STRABISMUS | 2018 |
|
RU2692459C1 |
| METHOD FOR IMPLANTATION OF AHMED ANTIGLAUCOMA VALVE | 2021 |
|
RU2771233C1 |
| METHOD OF TREATING VERTICAL SQUINT WITH HYPERFUNCTION OF INFERIOR OBLIQUE EYE MUSCLE | 2010 |
|
RU2436550C1 |
| METHOD FOR TREATMENT OF CONGENITAL GLAUCOMA | 2022 |
|
RU2790760C1 |
| METHOD FOR PROLONGING THE NEEDLING RESULTS OF THE SCAR-MODIFIED FILTRATION PAD | 2019 |
|
RU2734050C1 |
| SURGICAL METHOD FOR TREATING SMALL ANGLES OF SQUINT | 2000 |
|
RU2198636C2 |
| METHOD FOR RECURRENT PENETRATION SURGICAL MANAGEMENT OF GLAUCOMA | 2013 |
|
RU2533841C1 |
